Proteomics approaches towards antigen discovery and vaccine development

Current Opinion in Molecular Therapeutics

Volumn 4, Issue 3, 2002, Pages 216-223

  Klade, Christoph S ^a  

^a INTERCELL AG   (Austria)

Author keywords

Antigen; Cancer; Infectious disease; Proteomics; Serology; Vaccine

Indexed keywords

ANTIGEN; BCG VACCINE; IMMUNOGLOBULIN G; RECOMBINANT PROTEIN; VACCINE;

ANALYTIC METHOD; ANTIGEN STRUCTURE; ARTICLE; BCG VACCINATION; CANCER IMMUNOTHERAPY; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; DRUG DESIGN; DRUG RESEARCH; DRUG TARGETING; HUMAN; IMMUNE SYSTEM; IMMUNOBLOTTING; MICROBIAL GENETICS; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; PROTEIN ANALYSIS; PROTEOMICS; RECOMBINANT DNA TECHNOLOGY; SEROLOGICAL PROTEOME ANALYSIS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; TUBERCULOSIS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANTIGENS; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; CANCER VACCINES; FORECASTING; GENOME, BACTERIAL; HUMANS; IMMUNOTHERAPY, ACTIVE; PROTEOME; PROTEOMICS; SEQUENCE ANALYSIS, PROTEIN; VACCINES; VACCINES, SYNTHETIC;

CHLAMYDIA TRACHOMATIS; MYCOBACTERIUM; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; NEISSERIA; NEISSERIA MENINGITIDIS; STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE;

EID: 0036624291     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Nossal GJV: The global alliance for vaccines and immunization - a millennial challenge. Alat Zmmunot (2000) 1:5-8.
2. Wang MN, Chen WM, Lee KS, Chin LS, Lo WH: Tuberculous osteomyelitis in young children. J Pediatr Orthop (1999) 19:151-155.
3. Chen FIT, Pless R, Destefano F: Epidemiology of autoimmune reactions induced by vaccination. J Autoimmun (2001) 16:309-318.
4. Zauner W, Lingnau K, Mather F, von Gabain A, Buschle M: Defined synthetic vaccines. Biol Chem (2001) 382:581-595.
5. Buschle M, Schmidt W, Zauner W, Mechtler K, Trska B, Kirlappos H, Bimstiel ML: Transloading of tumor antigen-derived peptides into antigen-presenting cells. Proc Natl Aced Sci USA (1997) 94:3256-3261.
6. Schmidt W, Buschle M, Zauner W, Kirlappos H, Mechtler K, Trska B, Birnstiel ML: Cell-free tumor antigen peptide-based cancer vaccines. Proc Natl Acad Sci USA (1997) 94:3262-3267.
7. Mattner F, Fieltmann JK, Lingnau K, Schmidt W, Egyed A, Fritz J, Zauner W, Wittmann B, Gorny I, Berger M, Kirlappos H, Otava A, Birnstiel ML, Buschle M: Vaccination with poly-L-arginine as immunostimulant for peptide vaccines: Induction of potent and long-lasting T-cell responses against cancer antigens. Cancer Res (2002) 62:1477-1480.
8. Krieg AM, Wagner H: Causing a commotion in the blood: Immunotherapy progresses from bacteria to bacterial DNA. Immunol Today (2000) 21:521-526.
9. Pardoll DM: Cancer vaccines. Nat Med (1998) 4:525-531.
10. Washburn MP, Wolters D, Yates JR 3rd: Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol (2001) 19:242-247.
11. Gorg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber R, Weiss W: The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis (2000) 21:1037-1053.
12. Cordwell SJ, Nouwens AS, Walsh BJ: Comparative proteomics of bacterial pathogens. Proteomics (2001) 1:461-472.
13. Collins HL, Kaufmann SH: Prospects for better tuberculosis vaccines. Lancet Infect Dis (2001) 1:21-28.
14. Mattow J, Jungblut PR, Muller EC, Kaufmann SH: Identification of acidic, low molecular mass proteins of Mycobacterium tuberculosis strain H37Rv by matrix-assisted laser desorption/ionization and electrospray ionization mass spectrometry. Proteomics (2001) 1:494-507.
15. Sorensen AL, Nagai S, Houen G, Andersen P, Andersen AB: Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun (1995) 63:1710-1717.
16. Jungblut PR, MOller E-C, Mattow J, Kaufmann SHE: Proteomics reveals open reading frames in Mycobacterium tuberculosis H37Rv not predicted by genomics. Infect Immun (2001) 69:5905-5907.
17. Jungblut PR, Schaible UE, Mollenkopf HJ, Zimny-Arndt U, Raupach B, Mattow J, Halada P, Lamer S, Hagens K, Kaufmann SHE: Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: Towards functional genomics of microbial pathogens. Mol Microbiol (1999) 33:1103-1117.
18. Mattow J, Jungblut PR, Schaible UE, Mollenkopf HJ, Lamer S, Zimny-Arndt U, Hagens K, Müller EC, Kaufmann SH: Identification of proteins from Mycobacterium tuberculosis missing in attenuated Mycobacterium bovis BCG strains. Electrophoresis (2001) 22:2936-2946.
19. Marques MA, Chitale S, Brennan PJ, Pessolani MC: Mapping and identification of the major cell wall-associated components of Mycobacterium leprae. Infect Immun (1998) 66:2625-2631.
20. Shaw AC, Gevaert K, Demol H, Hoorelbeke B, Vandekerckhove J, Larsen MR, Roepstorff P, Holm A, Christiansen G, Birkelund S: Comparative proteome analysis of Chlamydia trachomatis serovar A, D and L2. Proteomics (2002) 2:164-186.
21. Hughes W, Moore JC, Lane JD, Wilson R, Pribul PK, Younes ZN, Dobson RJ, Everest P, Reason AJ, Redfem JM, Greer FM, Paxton T, Panico M, Morris FIR, Feldman RG, Santangelo JD: Identification of major outer surface proteins of Streptococcus agalactiae. Infect Immun (2002) 70:1254-1259.
22. Pizza M, Scarlato V, Masignani V, Giuliani MM, Arico B, Comanducci M, Jennings GT, Baldi L, Bartolini E, Capecchi B, Galeotti CL, Luzzi E, Manetti R, Marchetti E, Mora M, Nuti S, Ratti G, Santini L, Savino S, Scarselli M, Stomi E, Zuo P, Broeker M, Hundt E, Knapp B, Blair E, Mason T, Tettelin H, Hood DW, Jeffries AC, Saunders NJ, Granoff DM, Venter JC, Moxon ER, Grandi G, Rappuoli R: Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science (2000) 287:1816-1820.
23. Wizemann TM, Heinrichs JH, Adamou JE, Erwin AL, Kunsch C, Choi GH, Barash SC, Rosen CA, Masure HR, Tuomanen E, Gayle A, Brewah YA, Walsh W, Barren P, Lathigra R, Hanson M, Langermann S, Johnson S, Koenig S: Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. infect Immun (2001) 69:1593-1598.
24. Allan I, Cunningham TM, Lovett MA: Molecular cloning of the major outer membrane protein of Chisinydia trachomatis. Infect Immun (1984) 45:637-641.
25. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW Houghton M: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science (1989) 244:359-362.
26. Stockert E, Jager E, Chen YT, Scanlan MJ, Gout I, Karbach J, Arand M, Knuth A, Old LJ: A survey of the humoral Immune response of cancer patients to a panel of human tumor antigens. J Exp Med (1998) 187:1349-1354.
27. Klade CS, Krystek E, Ahom H, Voss T, Adolf GR: A new approach to tumor antigen discovery: Serological proteome analysis (SERPA) identifies two antigens of renal cell carcinoma. Cancer Vaccine Week, New York, NY, USA (1998).
28. Klade CS, Voss T, Krystek E, Ahom H, Zatloukall K, Pummer K, Adolf GR: Identification of tumor antigens in renal cell carcinoma by serological proteome analysis. Proteomics (2001) 1:890-898.
29. Tureci O, Sahin U, Vollmer E, Siemer S, Gottert E, Seitz G, Parkkila AK, Shah GN, Grubb JH, Pfreundschuh M, Sly WS: Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. Proc Natl Acad Sci USA (1998) 95:7608-7613.
30. Parkkila S, Rajaniemi H, Parkkila AK, Kivela J, Waheed A, Pastorekova S, Pastorek J, Sly WS: Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc Natl Acad Sci USA (2000) 97:2220-2224.
31. Prasannan L, Misek DE, Hinderer R, Michon J, Geiger JD, Hanash SM: Identification of β-tubulln isoforms as tumor antigens in neuroblastome. Clin Cancer Res (2000) 6:3949-3956.
32. Le Naour F, Misek DE, Krause MC, Deneux L, Giordano TJ, Scholl S, Hanash SM: Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin Cancer Res (2001) 7:3328-3335.
33. Brichory F, Beer D, Le Naour F, Giordano T, Hanash S: Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. Cancer Res (2001) 61:7908-7912.
34. Hibi K, Liu Q, Beaudry GA, Madden SL, Westra WH, Wehage SL, Yang SC, Heitmiller RF, Bertelsen AH, Sidransky D, Jan J: Serial analysis of gene expression in non-small cell lung cancer. Cancer Res (1998) 58:5690-5694.
35. Hibi K, Westra WH, Borges M, Goodman S, Sidransky D, Jan J: PGP9.5 as a candidate tumor marker for non-small-cell lung cancer. Am J Pathol (1999) 155:711-715.
36. Tezel E, Hibi K, Nagasaka T, Nakao A: PGP9.5 as a prognostic factor in pancreatic cancer. Clin Cancer Res (2000) 6:4764-4767.
37. Yamazaki T, Hibi K, Takase T, Tezel E, Nakayama H, Kasai Y, Ito K, Akiyama S, Nagasaka T, Nakao A: PGP9.5 as a marker for invasive colorectal cancer. Clin Cancer Res (2002) 8:192-195.
38. Vytvytska O, Nagy E, Blüggel M, Meyer HE, Kurzbauer R, Huber LA, Klade CS: Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis. Proteomics (2002) 2:580-590.
39. Josefsson E, McCrea KW, Ni Eidhin D, O'Connel D, Cox J, Hook M, Foster TJ: Three new members of the serine-aspartate repeat protein multigene family of Staphylococcus aureus. Microbiology (1998) 144:3387-3395.
40. Josefsson E, Hartford O, O'Brien L, Patti JM, Foster T: Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J Infect Dis (2001) 184:1572-1580.
41. Ziebandt AK, Weber H, Rudolph J, Schmid R, Höper D, Engelmann S, Hecker M: Extracellular proteins of Staphylococcus aureus and the role of Sar A and σB. Proteomics (2001) 1:480-493.
42. Lorenz U, Ohlsen K, Karch H, Hecker M, Thiede A, Hacker J: Human antibody response during sepsis against targets expressed by methicillin resistant Staphylococcus aureus. FEMS Immunol Med Microbiol (2000) 29:145-153.
43. De Lencastre H, Wu SW, Pinho MG, Ludovice AM, Filipe S, Gardete S, Sobral R, Gill S, Chung M, Tomasz A: Antibiotic resistance as a stress response: Complete sequencing of a large number of chromosomal loci in Staphylococcus aureus strain COL that impact on the expression of resistance to methicillin. Microb Drug Resist (1999) 5:163-175.
44. Cockayne A, Hill PJ, Powell NBL, Bishop K, Sims C, Williams P: Molecular cloning of a 32-kilodalton lipoprotein component of a novel iron-regulated Staphylococcus epidermidis ABC transporter. Infect Immun (1998) 66:3767-3774.
45. Haas G, Karaali G, Ebermayer K, Metzger WG, Lamer S, Zimny-Arndt U, Diescher S, Goebel UB, Vogt K, Roznowski AB, Wiedenmann BJ, Meyer TF, Aebischer T, Jungblut PR: Immunoproteomics of Heficobacter pylori infection and relation to gastric disease. Proteomics (2002) 2:313-324.
46. Kimmel B, Bosserhoff A, Frank R, Gross R, Goebel W, Beier D: Identification of immunodominant antigens from Helicobacter pylori and evaluation of their reactivities with sera from patients with different gastroduodenal pathologies. Infect Immun (2000) 68:915-920.
47. McAtee CP, Lim MY, Fung K, Velligan M, Fry K, Chow T, Berg DE: Identification of potential diagnostic and vaccine candidates of Helicobacter pylori by two-dimensional gel electrophoresis, sequence analysis, and serum profiling. Clin Diagn Lab Immunol (1998) 5:537-542.
48. Bumann D, Meyer TF, Jungblut PR: Proteome analysis of the common human pathogen Helicobacter pylori. Proteomics (2001) 1:473-479.
49. Pitarch A, Diez-Orejas R, Molero G, Pardo M, Sanchez M, Gil C, Nombela C: Analysis of the serologic response to systemic Candida albicans infection in a murine model. Proteomics (2001) 1:550-559.
50. Lei B, Mackie S, Lukomski S, Musser JM: Identification and immunogenicity of group A Streptococcus culture supernatant proteins. Infect Immun (2000) 68:6807-6818.
51. Covert BA, Spencer JS, Orme IM, Belisle JT: The application of proteomics in defining the T-cell antigens of Mycobacterium tuberculosis. Proteomics (2001) 1:574-586.
52. Etz H, Minh DB, Henics T, Dryla A, Winkler B, Triska C, Boyd AP, Söllner J, Schmidt W, von Ahsen U, Buschle M, Gill SR, Kolonay J, Khalak H, Fraser CM, von Gabain A, Nagy E, Meinke A: Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. Proc Natl Acad Sci USA (2002) 99:6573-6578.
53. Etz H, Minh DB, Schellack C, Nagy E, Meinke A: Bacterial phage receptors, versatile tools for display of polypeptides on the cell surface. J Bacteriol (2001) 183:6924-6935.
54. Gygi SP, Corthals GL, Zhang Y, Rochon Y, Aebersold R: Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci USA (2000) 97:9390-9395.
55. MacBeath G, Schreiber SL: Printing proteins as microarrays for high-throughput function determination. Science (2000) 289:1760-1763.
56. de Wildt RM, Mundy CR, Gorick BD, Tomlinson IM: Antibody arrays for high-throughput screening of antibody-antigen interactions. Nat Biotechnol (2000) 18:989-994.
57. Zhu H, Bilgin M, Bangham R, Hall D, Casamayor A, Bertone P, Lan N, Jansen R, Bidlingmaier S, Houfek T, Mitchell T, Miller P, Dean RA, Gerstein M, Snyder M: Global analysis of protein activities using proteame chips. Science (2001) 293:2101-2105.
58. Cahill DJ: Protein and antibody arrays and their medical applications. J Immunol Methods (2001) 250:81-91.